• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by CarParts.com Inc. (Amendment)

    12/22/23 4:29:07 PM ET
    $PRTS
    Auto & Home Supply Stores
    Consumer Discretionary
    Get the next $PRTS alert in real time by email
    SC 13D/A 1 e619148_sc13da-carparts.htm AMENDMENT NO. 9 TO THE SCHEDULE 13D

     

    UNITED STATES 

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

    ______________

     

    SCHEDULE 13D

    (Rule 13d-101)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    RULE 13d-2(a)

     

    (Amendment No. 9)1

     

    CARPARTS.COM, INC.

    (Name of Issuer)

     

    Common Stock, $0.001 par value

    (Title of Class of Securities)

     

    14427M107

    (CUSIP Number)

     

    Mr. David L. Kanen

    Kanen Wealth Management, LLC

    5850 Coral Ridge Drive, Suite 309

    Coral Springs, FL 33076

    (631) 863-3100

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    December 21, 2023

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ☐.

     

    Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

    (Continued on following pages)

     


    1      The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. 14427M107

      1   NAME OF REPORTING PERSON  
             
           

    PHILOTIMO FUND, LP

     
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐
            (b) ☒
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
           

    WC 

     
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
           

    DELAWARE

     
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING        

    1,713,363

     
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
             

    1,713,363

     
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
           

    1,713,363 

     
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
           

    3.0%

     
      14   TYPE OF REPORTING PERSON  
             
           

    IA, PN 

     

      

    CUSIP No. 14427M107

      1   NAME OF REPORTING PERSON  
             
           

    Philotimo Focused Growth and Income Fund

     
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐
            (b) ☒
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
           

    WC

     
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
           

    DELAWARE

     
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING        

    546,728

     
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
             

    546,728

     
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
           

    546,728

     
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
           

    Less than 1%

     
      14   TYPE OF REPORTING PERSON  
             
           

    IA, OO 

     

      

    CUSIP No. 14427M107

     

      1   NAME OF REPORTING PERSON  
             
           

    KANEN WEALTH MANAGEMENT, LLC

     
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐
            (b) ☒
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
           

    OO; AF

     
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
           

    FLORIDA

     
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING        

    2,555,537

     
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
             

    2,555,537

     
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
           

    2,555,537 

     
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
           

    4.4%

     
      14   TYPE OF REPORTING PERSON  
             
           

    IA, OO

     

      

    CUSIP No. 14427M107

     

      1   NAME OF REPORTING PERSON  
             
           

    DAVID L. KANEN

     
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐
            (b) ☒
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
           

    PF; OO 

     
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
           

    USA

     
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY        

    143,572

     
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING        

    2,555,537

     
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
             

    143,572 

     
        10   SHARED DISPOSITIVE POWER  
               
             

    2,555,537 

     
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
           

    2,699,109 

     
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
           

    4.7%

     
      14   TYPE OF REPORTING PERSON  
             
            IN  

     

    CUSIP No. 14427M107

     

    The following constitutes Amendment No. 9 to the Schedule 13D filed by the undersigned (“Amendment No. 9”). This Amendment No. 9 amends and restates the Schedule 13D as set forth herein.

     

    Item 3.Source and Amount of Funds or Other Consideration.

     

    Item 3 is hereby amended and restated to read as follows:

     

    The Shares purchased by Philotimo were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by PHLOX were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by KWM were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by Mr. Kanen were purchased with personal funds (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The aggregate purchase price of the 295,446 Shares beneficially owned by KWM is approximately $1,707,678, including brokerage commissions. The aggregate purchase price of the 1,713,363 Shares beneficially owned by Philotimo is approximately $10,400,113, including brokerage commissions. The aggregate purchase price of the 546,728 Shares beneficially owned by PHLOX is approximately $3,526,396, including brokerage commissions. The aggregate purchase price of the 143,572 Shares beneficially owned by Mr. Kanen is approximately $773,853, including brokerage commissions.

     

    Item 5.Interest in Securities of the Issuer.

     

    Items 5(a)-(c) and (e) are hereby amended and restated to read as follows:

     

    The aggregate percentage of Shares reported owned by each person named herein is based upon 57,498,607 Shares outstanding as of October 23, 2023 as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on October 31, 2023.

     

    A.Philotimo

     

    (a)As of the close of business on December 22, 2023, Philotimo beneficially owned 1,713,363 Shares.

     

    Percentage: Approximately 3.0%

     

    (b)1. Sole power to vote or direct vote: 0
    2. Shared power to vote or direct vote: 1,713,363
    3. Sole power to dispose or direct the disposition: 0
    4. Shared power to dispose or direct the disposition: 1,713,363

     

    (c)The transactions in the Shares by Philotimo during the past sixty days are set forth in Schedule A and are incorporated herein by reference.

     

    B.PHLOX

     

    (a)As of the close of business on December 22, 2023, PHLOX beneficially owned 546,728 Shares.

     

    CUSIP No. 14427M107

     

    Percentage: Less than 1%

     

    (b)1. Sole power to vote or direct vote: 0
    2. Shared power to vote or direct vote: 546,728
    3. Sole power to dispose or direct the disposition: 0
    4. Shared power to dispose or direct the disposition: 546,728

     

    (c)The transactions in the Shares by PHLOX during the past sixty days are set forth in Schedule A and are incorporated herein by reference.

     

    C.KWM

     

    (a)As of the close of business on December 22, 2023, KWM beneficially owned 2,555,537 Shares, consisting of (i) the 1,713,363 Shares owned directly by Philotimo, which KWM may be deemed to beneficially own as the general partner of Philotimo, (ii) the 546,728 Shares owned directly by PHLOX, which KWM may be deemed to beneficially own as the investment manager of PHLOX and (iii) 295,446 Shares directly owned by KWM.

     

    Percentage: Approximately 4.4%

     

    (b)1. Sole power to vote or direct vote: 0
    2. Shared power to vote or direct vote: 2,555,537
    3. Sole power to dispose or direct the disposition: 0
    4. Shared power to dispose or direct the disposition: 2,555,537

     

    (c)The transactions in the Shares by KWM during the past sixty days are set forth in Schedule A and are incorporated herein by reference. The transactions in the Shares by Philotimo and PHLOX are also set forth in Schedule A and incorporated by reference.

     

    D.Mr. Kanen

     

    (a)As of the close of business on December 22, 2023, Mr. Kanen directly beneficially owned 2,699,109 Shares, consisting of (i) 143,572 Shares directly owned by Mr. Kanen and (ii) 2,555,537 Shares beneficially owned by KWM, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM.

     

    Percentage: Approximately 4.7%

     

    (b)1. Sole power to vote or direct vote: 143,572
    2. Shared power to vote or direct vote: 2,555,537
    3. Sole power to dispose or direct the disposition: 143,572
    4. Shared power to dispose or direct the disposition: 2,555,537

     

    (b)Mr. Kanen has not transacted in the Shares during the past sixty days. The transactions in the Shares by KWM, Philotimo and PHLOX are also set forth in Schedule A and incorporated by reference.

     

    KWM, in its role as investment manager to the Accounts, to which it furnishes investment advice, and Mr. Kanen, as the managing member of KWM, may each be deemed to beneficially own shares of the Issuer’s Shares held in the Accounts.

     

    Each Reporting Person, as a member of a “group” with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, may be deemed the beneficial owner of the Shares directly owned by the other Reporting Persons. Each Reporting Person disclaims beneficial ownership of such Shares except to the extent of his or its pecuniary interest therein.

     

    (e)As of December 21, 2023 the Reporting Persons ceased to be the beneficial owners of more than 5% of the Shares of the Issuer.

      

    CUSIP No. 14427M107

     

    SIGNATURES

     

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Dated: December 22, 2023

     

      Kanen Wealth Management, LLC
       
      By: /s/ David L. Kanen
        Name: David L. Kanen
        Title: Managing Member

     

      Philotimo Fund, LP
       
      By: Kanen Wealth Management, LLC, its general partner
         
      By: /s/ David L. Kanen
        Name: David L. Kanen
        Title: Managing Member

     

      Philotimo Focused Growth and Income Fund
       
      By: Kanen Wealth Management, LLC, its investment adviser
         
      By: /s/ David L. Kanen
        Name: David L. Kanen
        Title: Managing Member

     

       
     

    /s/ David L. Kanen

      David L. Kanen

     

    CUSIP No. 14427M107

     

    SCHEDULE A

     

    Transactions in the Shares of the Issuer During the Past Sixty Days

     

    Nature of the Transaction

    Amount of Shares

    Purchased/(Sold) 

    Price ($)

    Date of

    Purchase/Sale

     

    PHILOTIMO FUND, LP

     

    Sale of Common Stock 12,428 3.4767 12/15/2023
    Sale of Common Stock 23,397 3.4181 12/19/2023
    Sale of Common Stock 58,341 3.4003 12/20/2023
    Sale of Common Stock 141,111 3.4002 12/21/2023

     

    PHILOTIMO FOCUSED GROWTH & INCOME FUND

     

    Sale of Common Stock 6,403 3.4767 12/15/2023
    Sale of Common Stock 12,053 3.4181 12/19/2023
    Sale of Common Stock 72,694 3.4002 12/21/2023


    KANEN WEALTH MANAGEMENT, llC (Through the Managed Accounts)

     

    Sale of Common Stock 20,000      3.18631 11/21/2023
    Sale of Common Stock 7,065      3.18162 11/22/2023

     


    1 The reported price represents a weighted average sale price. The range of prices at which the Shares were sold was $3.19 to $3.21 per share. The Reporting Person undertakes to provide to the Staff, the Issuer or a security holder full information regarding the number of shares sold at each separate price.

     

    2 The reported price represents a weighted average sale price. The range of prices at which the Shares were sold was $3.18 to $3.19 per share. The Reporting Person undertakes to provide to the Staff, the Issuer or a security holder full information regarding the number of shares sold at each separate price.

     

     

    Get the next $PRTS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PRTS

    DatePrice TargetRatingAnalyst
    3/6/2025$3.00Hold → Buy
    Craig Hallum
    3/4/2022$18.00Buy
    Lake Street
    12/28/2021$30.00 → $18.00Buy
    Roth Capital
    8/6/2021$18.00 → $21.00Outperform
    RBC Capital
    More analyst ratings